Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509379
Status:
COMPLETED
Last Update Posted:
2011-01-28
First Post:
2007-07-30
Brief Title:
Non-randomized Safety Study With BortezomibRituximab in RelapsedRefractory Indolent Lymphoma
Sponsor:
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Organization:
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2007-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-30
First Submit QC Date:
July 30 2007
Study First Post Date:
2007-07-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-01-27
Last Update Post Date:
2011-01-28
Last Update Post Date Type:
ESTIMATED